Skip to main content

Table 2 Her4 isoform-specific primers and probes

From: The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

JM-a

Forward

5′-CCA CCC ATC CCA TCC AAA-3′

 

Reverse

5′-CCA ATT ACT CCA GCT GCA ATC A-3′

 

Probe

5′-Fam-ATG GAC GGG CAA TTC CAC TTT ACC A-Dabcyl-3′

JM-b

Forward

5′-CCA CCC ATC CCA TCC AAA-3′

 

Reverse

5′-CCA ATT ACT CCA GCT GCA ATC A-3′

 

Probe

5′-Fam-CTC AAG TAT TGA AGA CTG CAT CGG CCT GAT-Dabcyl-3′

CYT1

Forward

5′-CAA CAT CCC ACC TCC CAT CTA TAC-3′

 

Reverse

5′-ACA CTC CTT GTT CAG CAG CAA A-3′

 

Probe

5′-Fam-TGA AAT TGG ACA CAG CCC TCC TCC TG-Dacyl-3′

CYT2

Forward

5′-CAA CAT CCC ACC TCC CAT CTA TAC-3′

 

Reverse

5′-ACA CTC CTT GTT CAG CAG CAA A-3′

 

Probe

5′-Fam-AAT TGA CTC GAA TAG GAA CCA GTT TGT ATA CCG AGA T-Dabcyl-3